Extrait

Phase II multicentric study comparing VAD regimen with continuous infusion over 96 hours of doxorubicin, vincristine and dexamethasone to a 90 minutes infusion of equivalent doses of Dox li-PEG, bolus infusion of vincristine and dexamethasone

Critère d'inclusion

• Acute Lymphoblastic Leukemia

Liens

• nct
• ictrp